Skip to main content
. 2015 May 15;10(6):934–940. doi: 10.2215/CJN.08620814

Table 2.

Association of BP with all-cause mortality

BP (mm Hg) Unadjusted Hazard Ratio (95% CI) Model 1 Hazard Ratio (95% CI) Model 2 Hazard Ratio (95% CI)
Systolic BP
 Q1 (≤128) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Q2 (>128–≤141) 0.94 (0.72 to 1.23) 0.90 (0.69 to 1.18) 0.94 (0.72 to 1.24)
 Q3 (>141–≤157) 0.96 (0.74 to 1.26) 0.92 (0.70 to 1.20) 0.99 (0.76 to 1.29)
 Q4 (>157) 1.61 (0.90 to 1.50) 1.15 (0.90 to 1.49) 1.17 (0.89 to 1.52)
Diastolic BP
 Q1 (≤64) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Q2 (>64–≤72) 0.76 (0.59 to 0.97) 0.81 (0.63 to 1.05) 0.91 (0.71 to 1.18)
 Q3 (>72–≤80) 0.70 (0.54 to 0.91) 0.84 (0.65 to 1.09) 0.97 (0.74 to 1.27)
 Q4 (>80) 0.74 (0.58 to 0.95) 1.01 (0.78 to 1.32) 1.16 (0.89 to 1.52)
Pulse pressure
 Q1 (≤57) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Q2 (>57–≤70) 0.98 (0.75 to 1.28) 0.86 (0.66 to 1.12) 0.78 (0.59 to 1.02)
 Q3 (>70–≤83) 1.14 (0.87 to 1.50) 0.97 (0.74 to 1.28) 0.94 (0.71 to 1.24)
 Q4 (>83) 1.39 (1.08 to 1.80) 0.97 (0.74 to 1.28) 1.01 (0.77 to 1.33)

Model 1: adjusted for age, sex, and race. Model 2: adjusted for covariates in model 1 plus smoking status, body mass index, history of hypertension, diabetes and cardiovascular disease, eGFR, serum hemoglobin, serum albumin, and Homocysteine in Kidney and ESRD randomized assignment. Q, quartile; 95% CI, 95% confidence interval.